• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清铁蛋白与骨髓增生异常综合征预后关系的系统文献综述

A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes.

作者信息

Oliva Esther Natalie, Huey Krystal, Deshpande Sohan, Turner Monica, Chitnis Madhura, Schiller Emma, Tang Derek, Yucel Aylin, Hughes Christina, Shah Farrukh

机构信息

Hematology Unit, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, 89124 Reggio Calabria, Italy.

Bristol Myers Squibb, Princeton, NJ 08540, USA.

出版信息

J Clin Med. 2022 Feb 8;11(3):895. doi: 10.3390/jcm11030895.

DOI:10.3390/jcm11030895
PMID:35160344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836890/
Abstract

Anemia is the most common form of cytopenia in patients with myelodysplastic syndromes (MDS), who require chronic red blood cell transfusions and may present high serum ferritin (SF) levels as a result of iron overload. To better understand the potential effects of high SF levels, we conducted a systematic literature review (SLR) to identify evidence on the relationship between SF levels and clinical, economic, or humanistic outcomes in adult patients with MDS. Of 267 references identified, 21 were included. No studies assessing SF levels and their relationship with humanistic or economic outcomes were identified. Increased SF levels were an indicator of worse overall survival and other worsened outcomes; however, the association was not consistently significant. SF levels were a significant prognostic factor for relapse incidence of MDS and showed a significant positive correlation with number of blood units transfused but were not associated with progression to acute myeloid leukemia or the time to transformation. Higher SF levels were also an indicator of a lower likelihood of leukemia-free survival, relapse-free survival, and event-free survival. The SLR suggests that SF levels are associated with clinical outcomes in MDS, with higher levels correlated with number of blood units transfused, frequently indicating worse outcomes.

摘要

贫血是骨髓增生异常综合征(MDS)患者中最常见的血细胞减少形式,这些患者需要长期输注红细胞,并且由于铁过载可能出现高血清铁蛋白(SF)水平。为了更好地了解高SF水平的潜在影响,我们进行了一项系统文献综述(SLR),以确定关于成年MDS患者SF水平与临床、经济或人文结局之间关系的证据。在识别出的267篇参考文献中,纳入了21篇。未发现评估SF水平及其与人文或经济结局关系的研究。SF水平升高是总体生存率较差和其他不良结局的一个指标;然而,这种关联并不始终显著。SF水平是MDS复发发生率的一个重要预后因素,与输注的血液单位数量呈显著正相关,但与进展为急性髓系白血病或转化时间无关。较高的SF水平也是无白血病生存、无复发生存和无事件生存可能性较低的一个指标。该系统文献综述表明,SF水平与MDS的临床结局相关,较高水平与输注的血液单位数量相关,通常表明结局较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681d/8836890/35aa7aac3669/jcm-11-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681d/8836890/35aa7aac3669/jcm-11-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681d/8836890/35aa7aac3669/jcm-11-00895-g001.jpg

相似文献

1
A Systematic Literature Review of the Relationship between Serum Ferritin and Outcomes in Myelodysplastic Syndromes.血清铁蛋白与骨髓增生异常综合征预后关系的系统文献综述
J Clin Med. 2022 Feb 8;11(3):895. doi: 10.3390/jcm11030895.
2
Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.红细胞输血依赖和高铁蛋白血症与骨髓增生异常综合征患者的生存受损相关:来自波兰 MDS-PALG 登记处的首个研究结果。
Adv Clin Exp Med. 2016 Jul-Aug;25(4):633-41. doi: 10.17219/acem/62397.
3
Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome.诊断时血清铁蛋白水平对骨髓增生异常综合征的预后意义。
Int J Hematol. 2012 May;95(5):527-34. doi: 10.1007/s12185-012-1048-3. Epub 2012 Mar 11.
4
Association between red blood cell transfusion dependence and burden in patients with myelodysplastic syndromes: A systematic literature review and meta-analysis.骨髓增生异常综合征患者红细胞输血依赖与负担的相关性:系统文献回顾和荟萃分析。
Eur J Haematol. 2021 Jul;107(1):3-23. doi: 10.1111/ejh.13619. Epub 2021 Apr 14.
5
Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review.β地中海贫血患者血清铁蛋白与预后的关系:一项系统文献综述
J Clin Med. 2022 Jul 30;11(15):4448. doi: 10.3390/jcm11154448.
6
[Detection of Hepcidin in transfusion dependent myelodysplastic syndrome patients and its clinical significance].[输血依赖型骨髓增生异常综合征患者中铁调素的检测及其临床意义]
Zhonghua Xue Ye Xue Za Zhi. 2011 Nov;32(11):758-61.
7
Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies.血清铁蛋白水平在骨髓增生异常综合征患者总生存中的作用:观察性研究的Meta分析结果
PLoS One. 2017 Jun 16;12(6):e0179016. doi: 10.1371/journal.pone.0179016. eCollection 2017.
8
Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis.血清铁蛋白和铁过载对急性髓系白血病结局的影响:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2951-2962. doi: 10.31557/APJCP.2024.25.8.2951.
9
The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.铁螯合疗法对低/中危国际预后评分系统(IPSS)骨髓增生异常综合征(MDS)患者的影响及血清铁蛋白升高在MDS和急性髓系白血病(AML)患者中的预后作用:一项荟萃分析。
Medicine (Baltimore). 2019 Oct;98(40):e17406. doi: 10.1097/MD.0000000000017406.
10
Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.红细胞输注与铁过载在骨髓增生异常综合征患者治疗中的应用
Cancer. 2008 Mar 1;112(5):1089-95. doi: 10.1002/cncr.23280.

引用本文的文献

1
Latest Insights and Therapeutic Advances in Myelodysplastic Neoplasms.骨髓增生异常综合征的最新见解与治疗进展
Cancers (Basel). 2024 Apr 19;16(8):1563. doi: 10.3390/cancers16081563.
2
Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country.骨髓增生异常综合征和骨髓增生异常综合征/骨髓增殖性肿瘤:来自发展中国家的真实世界经验。
JCO Glob Oncol. 2024 Feb;10:e2300281. doi: 10.1200/GO.23.00281.
3
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia.

本文引用的文献

1
Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survival.异基因造血干细胞移植治疗骨髓增生异常综合征-影响生存的因素。
Eur J Haematol. 2020 Feb;104(2):116-124. doi: 10.1111/ejh.13353. Epub 2019 Dec 2.
2
In myelodysplastic syndrome cases, what should be the level of ferritin which has prognostic value?在骨髓增生异常综合征病例中,具有预后价值的铁蛋白水平应该是多少?
Transfus Clin Biol. 2019 Nov;26(4):217-223. doi: 10.1016/j.tracli.2019.07.005. Epub 2019 Aug 5.
3
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.
羧基麦芽糖铁与促红细胞生成素治疗可降低难治性贫血的输血率。
J Clin Med. 2022 Aug 14;11(16):4744. doi: 10.3390/jcm11164744.
4
Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies.铁及铁过载在血液系统恶性肿瘤患者侵袭性真菌感染发病机制中的作用
J Clin Med. 2022 Jul 30;11(15):4457. doi: 10.3390/jcm11154457.
诊断时的血清铁蛋白水平可预测低原始细胞骨髓增生异常综合征患者的预后。
Int J Hematol. 2019 Nov;110(5):533-542. doi: 10.1007/s12185-019-02710-1. Epub 2019 Jul 29.
4
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation.一项关于输血负担和相关铁毒性对接受异基因造血细胞移植的骨髓增生异常综合征患者结局影响的前瞻性非干预性研究。
Leuk Lymphoma. 2019 Oct;60(10):2404-2414. doi: 10.1080/10428194.2019.1594215. Epub 2019 Apr 18.
5
Chronic myelomonocytic leukemia treated with 5-azacytidine - results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system.用 5-氮杂胞苷治疗慢性粒单核细胞白血病-来自希腊 5-氮杂胞苷登记处的结果:提出一个新的风险分层系统。
Leuk Lymphoma. 2019 Jul;60(7):1721-1730. doi: 10.1080/10428194.2018.1540783. Epub 2018 Nov 14.
6
Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit?低国际预后评分系统(IPSS)风险骨髓增生异常综合征的铁螯合疗法;哪些亚型会从中获益?
Leuk Res. 2018 Jan;64:24-29. doi: 10.1016/j.leukres.2017.11.005. Epub 2017 Nov 11.
7
Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.红细胞输血依赖和高铁蛋白血症与骨髓增生异常综合征患者的生存受损相关:来自波兰 MDS-PALG 登记处的首个研究结果。
Adv Clin Exp Med. 2016 Jul-Aug;25(4):633-41. doi: 10.17219/acem/62397.
8
Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome.血色素沉着症基因突变可能影响骨髓增生异常综合征患者的生存。
Hematology. 2016 Apr;21(3):170-4. doi: 10.1080/10245332.2015.1101964. Epub 2016 Mar 30.
9
Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome.药物依从性对去铁胺治疗骨髓增生异常综合征输血性铁过载疗效的影响。
J Clin Pharm Ther. 2016 Feb;41(1):59-63. doi: 10.1111/jcpt.12348. Epub 2016 Jan 18.
10
Incidence and Burden of the Myelodysplastic Syndromes.骨髓增生异常综合征的发病率和负担
Curr Hematol Malig Rep. 2015 Sep;10(3):272-81. doi: 10.1007/s11899-015-0269-y.